All In MedTech

FDA Clearance Tracker · P980046-S002

HEPATITIS C CHECK TESTING SERVICE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 12, 2000 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 12, 2000

30-day notice accepted

Time to decision

20 days

Received Mar 23, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

30-Day Notice

Device class

Class II

The decision

FDA number
P980046-S002
Device name
HEPATITIS C CHECK TESTING SERVICE
Applicant location
New York, NY
Received
Mar 23, 2000
Decided
Apr 12, 2000
Decision
30-day notice accepted
Supplement type
30-Day Notice
Original approval
P980046

Device type

Device class
Class II
Regulation
21 CFR 866.3169

Every decision under product code MZO

FDA's approval statement

As written in FDA's record.

As a final packaging option, the outer packaging of the Hepatitis C Check product may be assembled in a Softpak package or the currently approved paperboard packaging when shipped directly to clients.

Source documents

Other decisions for Pwn Health Chicago, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.